|
|
 |
|
|
 |
|
 |
|
Volume 11, Issue 3 (Jul-Sep 2024) |
 |
|
|
|
|
Limosilactobacillus fermentum RSB9: Isolation and Identification, Viability in Acidic and Bile Conditions, Antimicrobial Activity, Antioxidant Power, and Safety Properties |
P. 1-10 |
|
Behrooz Alizadeh Behbahani *    , Hossein Hossein Jooyandeh , Heidar Rafiee |
|
Abstract
(1153 Views) |
Full-Text (PDF)
(363 Downloads)
| Graphical Abstract
| Highlights
- The antimicrobial potential of Limosilactobacillus fermentum RSB9 was evaluated using agar diffusion methods with wells and disc diffusion in agar, revealing strong antimicrobial activity against the investigated pathogenic species.
- L. fermentum RSB9 did not exhibit any hemolytic or DNase activity and was unable to produce biogenic amines.
- The antioxidant activity of L. fermentum RSB9 using DPPH and ABTS methods was determined to be 48.90% ± 0.57 and 52.50% ± 0.43, respectively, demonstrating a high potential for inhibiting free radicals.
- The surface hydrophobicity of L. fermentum RSB9 was measured to be 54.09 ± 0.40%, with its ability to absorb cholesterol measured as 43.60 ± 0.45%.
|
|
Combination Therapy of Flaxseed and Hesperidin Enhances the Effectiveness of Lifestyle Modification in Metabolic Syndrome: A Randomized Controlled Clinical Trial |
P. 11-20 |
|
Azita Hekmatdoost , Vahideh Behrouz , Zahra Yari * |
|
Abstract
(956 Views) |
Full-Text (PDF)
(320 Downloads)
| Highlights
- Supplementing with flaxseed and hesperidin improved more than three factors of metabolic syndrome in 46% of patients.
- Supplementing with flaxseed and hesperidin caused a significant weight loss.
- Supplementing with flaxseed and hesperidin improved systolic blood pressure.
- Supplementing with flaxseed and hesperidin improved glycemic control.
|
|
Potential of Resveratrol in Cardiovascular Disorders – A Systematic Review |
P. 21-36 |
|
Jaskomal Phagoora * , Mark Wanis , Brett Agrest , Moshe Kabariti , Domaldy Dejesus , Arshia Hamzehpour , Sukhpreet Saini , Agha Abbas , Jisha Reji , Sarthak Bakilwal |
|
Abstract
(1340 Views) |
Full-Text (PDF)
(579 Downloads)
| Graphical Abstract
| Highlights
- Resveratrol has been shown to lower LDL cholesterol and triglycerides while increasing HDL cholesterol
- Resveratrol promotes nitric oxide (NO) production, leading to vasodilation and reduced blood pressure.
- Resveratrol has shown promise in reducing cardiac fibrosis, inhibiting ventricular hypertrophy, and improving overall cardiac function
- Resveratrol offers potential therapeutic benefits for ischemic stroke patients by reducing inflammation, promoting neurogenesis and angiogenesis.
- Resveratrol has been effective in reducing oxidative stress and improving cardiac function in Chagas heart disease.
|
|
|
|
|
|
|
|
|
|
